Moreover, to verify the stemness of these cells, we isolated CD133–, CD133+, CD184–, CD184+, CD271–, CD271+, CD344–, and CD344+ MSCs in the SHP2E76K group and performed the in vivo tumor growth assay. The gene discussed is NGFR; the disease is neoplasm.